OncoCyte Market Cap 2014-2023 | OCX

OncoCyte market cap history and chart from 2014 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. OncoCyte market cap as of April 24, 2024 is $0.02B.
Sector Industry Market Cap Revenue
Medical Medical Services $0.020B $0.002B
OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $124.048B 15.56
Cencora (COR) United States $47.467B 18.94
ICON (ICLR) Ireland $25.527B 24.10
DiDi Global (DIDIY) China $23.901B 0.00
Avantor (AVTR) United States $17.269B 23.79
Viatris (VTRS) United States $13.856B 3.96
CochLear (CHEOY) $13.551B 0.00
Revvity (RVTY) United States $12.684B 22.08
Charles River Laboratories (CRL) United States $12.333B 22.48
Medpace Holdings (MEDP) United States $12.318B 40.53
EUROFINS SCIENT (ERFSF) Luxembourg $11.750B 0.00
Natera (NTRA) United States $11.049B 0.00
Solventum (SOLV) United States $10.961B 0.00
Amplifon S.p.A (AMFPF) Italy $7.290B 37.01
HealthEquity (HQY) United States $6.795B 50.77
Bausch + Lomb (BLCO) Canada $5.236B 20.14
Organon (OGN) United States $4.783B 4.63
Doximity (DOCS) United States $4.461B 33.21
PACS (PACS) United States $3.596B 0.00
Surgery Partners (SGRY) United States $3.228B 30.00
Sotera Health (SHC) United States $3.190B 15.65
Progyny (PGNY) United States $3.133B 52.58
Life Times (LTH) United States $2.882B 31.85
GoodRx Holdings (GDRX) United States $2.749B 139.20
Premier (PINC) United States $2.531B 9.26
Teladoc Health (TDOC) United States $2.325B 0.00
Agilon Health (AGL) United States $2.191B 0.00
AMN Healthcare Services Inc (AMN) United States $2.167B 7.01
BrightSpring Health Services (BTSG) United States $1.845B 0.00
Agiliti (AGTI) United States $1.374B 22.44
Establishment Labs Holdings (ESTA) $1.344B 0.00
NovoCure (NVCR) Jersey $1.328B 0.00
Alignment Healthcare (ALHC) United States $0.979B 0.00
Pediatrix Medical (MD) United States $0.776B 8.03
Embecta (EMBC) United States $0.627B 4.14
Auna S.A (AUNA) Luxembourg $0.558B 0.00
InnovAge Holding (INNV) United States $0.542B 0.00
Enhabit (EHAB) United States $0.510B 46.23
COMPASS Pathways (CMPS) United Kingdom $0.502B 0.00
LifeMD (LFMD) United States $0.450B 0.00
Sonida Senior Living (SNDA) United States $0.423B 0.00
CareDx (CDNA) United States $0.413B 0.00
Beauty Health (SKIN) United States $0.389B 0.00
MultiPlan (MPLN) United States $0.375B 0.00
DocGo (DCGO) United States $0.367B 58.67
ModivCare (MODV) United States $0.353B 4.68
Sera Prognostics (SERA) United States $0.326B 0.00
GeneDx Holdings (WGS) United States $0.308B 0.00
Sharecare (SHCR) United States $0.277B 0.00
Ascend Wellness Holdings (AAWH) United States $0.265B 0.00
Biodesix (BDSX) United States $0.145B 0.00
So-Young (SY) China $0.121B 40.67
Oncology Institute (TOI) United States $0.089B 0.00
Pono Capital Two (PTWO) United States $0.077B 0.00
IceCure Medical (ICCM) Israel $0.056B 0.00
NeueHealth (NEUE) United States $0.053B 0.00
Co-Diagnostics (CODX) United States $0.036B 0.00
Nutex Health (NUTX) United States $0.033B 0.00
Singular Genomics Systems (OMIC) United States $0.030B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
SeaStar Medical Holding (ICU) United States $0.028B 0.00
DermTech (DMTK) United States $0.021B 0.00
Aesthetic Medical Hldngs Group (AIH) China $0.014B 0.00
BIMI Holdings (BIMI) United States $0.014B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
TRxADE HEALTH (MEDS) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
OpGen (OPGN) United States $0.007B 0.00
NewGenIvf Group (NIVF) Singapore $0.006B 0.00
Assure Holdings (IONM) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00